FDA Approves First Over-the-Counter Nasal Spray for Opioid Overdoses
WEDNESDAY, March 29, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved the over-the-counter (OTC) use of naloxone (Narcan).”Today’s approval of OTC naloxone nasal spray will help improve access to naloxone, increase …
Learn MoreNirmatrelvir Cuts Risk for Post-COVID-19 Condition
MONDAY, March 27, 2023 (HealthDay News) — Treatment with nirmatrelvir during the acute phase of COVID-19 may reduce the risk for postacute adverse health outcomes, according to a study published online March 23 in JAMA Internal Medicine.Yan Xie, Ph.D…
Learn MoreUn panel de la FDA reevaluará el mérito de un descongestionante que muchos califican de inútil
LUNES, 6 de marzo de 2023 (HealthDay News) — Hace años que los consumidores utilizan un descongestionante oral de venta libre llamado fenilefrina, pero quizá esta situación no continúe mucho tiempo.La Administración de Alimentos y Medicamentos (FDA) …
Learn MoreFDA Panel to Again Weigh Merit of Decongestant That Many Call Useless
MONDAY, March 6, 2023 (HealthDay News) — Consumers have been using the common over-the-counter oral decongestant phenylephrine for years, but that may not continue much longer. The U.S. Food and Drug Administration has asked a panel of its advisers t…
Learn MoreFDA Panel to Again Weigh Merit of Decongestant That Many Call Useless
MONDAY, March 6, 2023 (HealthDay News) — Consumers have been using a common over-the-counter oral decongestant known as phenylephrine for years, but that may not continue much longer.The U.S. Food and Drug Administration has asked a panel of its advi…
Learn MoreFDA Widens Warning for Contaminated Eye Products
WEDNESDAY, Feb. 22, 2023 (HealthDay News) — On Wednesday, the U.S. Food and Drug Administration warned consumers to stop buying or using the Delsam Pharma Artificial Eye Ointment. The over-the-counter product is made by the same company that makes ey…
Learn MorePoll Reveals Many Parents Too Quick to Give Fever Meds to Children
TUESDAY, Feb. 21, 2023 (HealthDay News) — A new poll from Michigan Medicine showed that about one-third of parents reach for fever-reducing medicines too quickly.”Some parents may immediately rush to give their kids medicine, but it’s often better to…
Learn MoreFDA Panel Says Opioid Overdose Antidote Safe to Sell Over the Counter
THURSDAY, Feb. 16, 2023 (HealthDay News) — A nasal spray that can reverse an opioid overdose should be sold over the counter, two expert panels to the U.S. Food and Drug Administration recommended Wednesday. Research has shown that wider availability…
Learn MoreDrugs With Low Clinical Benefit Show Higher Direct-to-Consumer Spending
WEDNESDAY Feb. 15, 2023 (HealthDay News) — Among the top-selling U.S. drugs, those with lower added clinical benefit ratings and higher total drug sales have higher manufacturer spending on direct-to-consumer advertising, according to a study publish…
Learn MoreFDA Panel Considers Making Opioid Overdose Antidote More Easily Obtainable
WEDNESDAY, Feb. 15, 2023 (HealthDay News) — U.S. Food and Drug Administration advisers are meeting Wednesday to discuss making generic naloxone hydrochloride available without requiring interaction with a pharmacist, CNN reported. Approval could happ…
Learn More